Article Versions Notes

Al-Kharashi LA, Badr AM, Atawia RT, Elmongy EI, Henidi H, Ali R, Binmughram AA, Al-Abkka L, Bayoumy NMK, Mahran YF. Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol’s Potential Inhibitory and Protective Effects. Pharmaceuticals. 2025; 18(11):1686. https://doi.org/10.3390/ph18111686

Al-Kharashi, Layla A., Amira M. Badr, Reem T. Atawia, Elshaymaa I. Elmongy, Hanan Henidi, Rehab Ali, Awatif A. Binmughram, Lian Al-Abkka, Nervana Mostafa Kamal Bayoumy, and Yasmen F. Mahran. 2025. "Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol’s Potential Inhibitory and Protective Effects" Pharmaceuticals 18, no. 11: 1686. https://doi.org/10.3390/ph18111686

Al-Kharashi, L. A., Badr, A. M., Atawia, R. T., Elmongy, E. I., Henidi, H., Ali, R., Binmughram, A. A., Al-Abkka, L., Bayoumy, N. M. K., & Mahran, Y. F. (2025). Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol’s Potential Inhibitory and Protective Effects. Pharmaceuticals, 18(11), 1686. https://doi.org/10.3390/ph18111686